MDLN

Medline Stock Analysis

AI Rating

Neutral
  • Quality3/10
  • Growth↓ 3/10
  • Value↓ 2/10
Medline sales and earnings growth
MDLN Growth
Neutral
  • Revenue Y/Y↑ 22.39%
  • EPS Y/Y↓ 0.00%
  • FCF Y/Y↓ -8.01%
Medline gross and profit margin trends
MDLN Profitability
Good
  • Gross margin ↑ 26.40%
  • EPS margin↓ 4.10%
  • ROIC 5Y↓ 0.00%
Medline net debt vs free cash flow
MDLN Risk
Great
  • Debt / Equity↓ 0.7
  • Debt / FCF↑ 8.2
  • Interest coverage↓ 2.5

Medline stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Medical Instruments & Supplies stocks ↗